دورية أكاديمية
Percutaneous ventricular assist device for higher-risk percutaneous coronary intervention in surgically ineligible patients: Indications and outcomes from the OPTIMUM study.
| العنوان: | Percutaneous ventricular assist device for higher-risk percutaneous coronary intervention in surgically ineligible patients: Indications and outcomes from the OPTIMUM study. |
|---|---|
| المؤلفون: | Hirai T; Division of Cardiology, University of Missouri, Columbia, Missouri, USA., Grantham JA; Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA.; Divison of Cardiology, University of Missouri Kansas City, Kansas City, Missouri, USA., Kandzari DE; Piedmont Heart Institute, Atlanta, Georgia, USA., Ballard W; Piedmont Heart Institute, Atlanta, Georgia, USA., Brown WM; Piedmont Heart Institute, Atlanta, Georgia, USA., Allen KB; Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA.; Divison of Cardiology, University of Missouri Kansas City, Kansas City, Missouri, USA., Kirtane AJ; Columbia University Irving Medical Center/NewYork-Presbyterian Hospital and the Cardiovascular Research Foundation, New York, New York, USA., Argenziano M; Columbia University Irving Medical Center/NewYork-Presbyterian Hospital and the Cardiovascular Research Foundation, New York, New York, USA., Yeh RW; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Khabbaz K; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Lombardi W; Divsion of Cardiology, University of Washington, Seattle, Washington, USA., Lasala J; Division of Cardiology, Washington University, St. Louis, Missouri, USA., Kachroo P; Division of Cardiology, Washington University, St. Louis, Missouri, USA., Karmpaliotis D; Morristown Medical Center, Morristown, New Jersey, USA., Gosch KL; Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA., Salisbury AC; Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA.; Divison of Cardiology, University of Missouri Kansas City, Kansas City, Missouri, USA. |
| مؤلفون مشاركون: | OPTIMUM Study Group |
| المصدر: | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2023 Nov; Vol. 102 (5), pp. 814-822. Date of Electronic Publication: 2023 Sep 07. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 100884139 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-726X (Electronic) Linking ISSN: 15221946 NLM ISO Abbreviation: Catheter Cardiovasc Interv Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: New York, NY : Wiley-Liss, c1999- |
| مواضيع طبية MeSH: | Percutaneous Coronary Intervention*/adverse effects , Heart-Assist Devices*, Humans ; Stroke Volume ; Prospective Studies ; Treatment Outcome ; Retrospective Studies ; Ventricular Function, Left ; Shock, Cardiogenic/therapy |
| مستخلص: | Background: Indications and outcomes for percutaneous ventricular assist device (pVAD) use in surgically ineligible patients undergoing percutaneous coronary intervention (PCI) remain poorly characterized. Aims: We sought to describe the use and timing of pVAD and outcome in surgically ineligible patients. Methods: Among 726 patients enrolled in the prospective OPTIMUM study, clinical and health status outcomes were assessed in patients who underwent pVAD-assisted PCI and those without pVAD. Results: Compared with patients not receiving pVAD (N = 579), those treated with pVAD (N = 142) more likely had heart failure, lower left ventricular ejection fraction (30.7 ± 13.6 vs. 45.9 ± 15.5, p < 0.01), and higher STS 30-day predicted mortality (4.2 [2.1-8.0] vs. 3.3 [1.7-6.6], p = 0.01) and SYNTAX scores (36.1 ± 12.2, vs. 31.5 ± 12.1, p < 0.01). While the pVAD group had higher in-hospital (5.6% vs. 2.2%, p = 0.046), 30-day (9.0% vs. 4.0%, p = 0.01) and 6-month (20.4% vs. 11.7%, p < 0.01) mortality compared to patients without pVAD, this difference appeared to be largely driven by significantly higher mortality among the 20 (14%) patients with unplanned pVAD use (30% in-hospital mortality with unplanned PVAD vs. 1.6% with planned, p < 0.01; 30-day mortality, 38.1% vs. 4.5%, p < 0.01). The degree of 6-month health status improvement among survivors was similar between groups. Conclusion: Surgically ineligible patients with pVAD-assisted PCI had more complex baseline characteristics compared with those without pVAD. Higher mortality in the pVAD group appeared to be driven by very poor outcomes by patients with unplanned, rescue pVAD. (© 2023 Wiley Periodicals LLC.) |
| References: | Kirtane AJ, Doshi D, Leon MB, et al. Treatment of Higher-Risk patients with an indication for revascularization: evolution within the field of contemporary percutaneous coronary intervention. Circulation. 2016;134:422-431. Stretch R, Sauer CM, Yuh DD, Bonde P. National trends in the utilization of Short-Term mechanical circulatory support. JACC. 2014;64:1407-1415. O'Neill WW, Kleiman NS, Moses J, et al. A prospective, randomized clinical trial of hemodynamic support with impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation. 2012;126:1717-1727. Amin AP, House JA, Safley DM, et al. Costs of transradial percutaneous coronary intervention. JACC. 2013;6:827-834. Dhruva SS, Ross JS, Mortazavi BJ, et al. Association of use of an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump with In-Hospital mortality and major bleeding among patients with acute myocardial infarction complicated by cardiogenic shock. JAMA. 2020;323:734-745. Briasoulis A, Telila T, Palla M, et al. Meta-Analysis of usefulness of percutaneous left ventricular assist devices for High-Risk percutaneous coronary interventions. Am J Cardiol. 2016;118:369-375. Spertus JA, Jones PG, Maron DJ, et al. Health-Status outcomes with invasive or conservative care in coronary disease. N Engl J Med. 2020;382:1408-1419. Spertus JA, Jones PG, Maron DJ, et al. Health status after invasive or conservative care in coronary and advanced kidney disease. N Engl J Med. 2020;382:1619-1628. Salisbury AC, Grantham JA, Brown WM, et al. Outcomes of medical therapy plus PCI for multivessel or left main CAD ineligible for surgery. JACC. 2023;16:261-273. Salisbury AC, Kirtane AJ, Ali ZA, et al. The outcomes of percutaneous RevascularizaTIon for management of SUrgically ineligible patients with multivessel or left main coronary artery disease (OPTIMUM) registry: rationale and design. Cardiovasc Revascularizat Med. 2022;41:83-91. Patel MR, Calhoon JH, Dehmer GJ, et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a report of the American college of cardiology appropriate use criteria task force, American association for thoracic surgery, American heart association, American society of echocardiography, American society of nuclear cardiology, society for cardiovascular angiography and interventions, society of cardiovascular computed tomography, and society of thoracic surgeons. JACC. 2017;69:2212-2241. Farooq V, Serruys PW, Bourantas CV, et al. Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score. Circulation. 2013;128:141-151. Spertus JA, Winder JA, Dewhurst TA, et al. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. JACC. 1995;25:333-341. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. JACC. 2000;35:1245-1255. Mozaffarian D, Bryson CL, Spertus JA, McDonell MB, Fihn SD. Anginal symptoms consistently predict total mortality among outpatients with coronary artery disease. Am Heart J. 2003;146:1015-1022. Spertus JA, Jones P, McDonell M, Fan V, Fihn SD. Health status predicts long-term outcome in outpatients with coronary disease. Circulation. 2002;106:43-49. Arnold SV, Kosiborod M, Li Y, et al. Comparison of the Seattle angina questionnaire with daily angina diary in the TERISA clinical trial. Circulat Cardiovasc Qual Outco. 2014;7:844-850. Chan PS, Jones PG, Arnold SA, Spertus JA. Development and validation of a short version of the Seattle angina questionnaire. Circ Cardiovas Qual Outco. 2014;7:640-647. Spertus J, Peterson E, Conard MW, et al. Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J. 2005;150:707-715. Amin AP, Spertus JA, Curtis JP, et al. The evolving landscape of impella use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support. Circulation. 2020;141:273-284. O'Neill BP, Grines C, Moses JW, et al. Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing nonemergent percutaneous coronary intervention. Catheter Cardiovasc Interv. 2021;98:E501-E512. Lüsebrink E, Kellnar A, Krieg K, et al. Percutaneous transvalvular microaxial flow pump support in cardiology. Circulation. 2022;145:1254-1284. Mark DB, Knight JD, Velazquez EJ, et al. Quality-of-life outcomes with coronary artery bypass graft surgery in ischemic left ventricular dysfunction: a randomized trial. Ann Intern Med. 2014;161:392-399. |
| معلومات مُعتمدة: | Boston Scientific Corporation; Abiomed |
| فهرسة مساهمة: | Keywords: high-risk percutaneous coronary intervention; percutaneous ventricular assist device; quality of life; surgical ineligible |
| تواريخ الأحداث: | Date Created: 20230907 Date Completed: 20231115 Latest Revision: 20231121 |
| رمز التحديث: | 20231215 |
| DOI: | 10.1002/ccd.30834 |
| PMID: | 37676058 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1522-726X |
|---|---|
| DOI: | 10.1002/ccd.30834 |